Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Surmodics Inc SRDX

Healthcare Medical Devices
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve... see more

Recent & Breaking News (NDAQ:SRDX)

Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results

Business Wire July 31, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRCL, IBTX, AGS, SRDX on Behalf of Shareholders

PR Newswire July 17, 2024

SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX

Business Wire July 17, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRDX, PRFT, HTLF on Behalf of Shareholders

Accesswire July 3, 2024

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. - SRDX

PR Newswire July 3, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCP, SRDX, CALB, FFNW on Behalf of Shareholders

PR Newswire June 17, 2024

Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm

PR Newswire June 17, 2024

Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.

Business Wire June 10, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRO, ATRI, SRDX, AKLI on Behalf of Shareholders

PR Newswire June 6, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRCL, AMBC, SGRP, SRDX

Accesswire June 5, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Surmodics, Inc. Buyout

Newsfile June 4, 2024

SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate SRCL, MRO, SRDX, ATRI

PR Newswire June 3, 2024

Lifshitz Law PLLC Announces Investigations of SRDX, IBTX, CALT, and ATRI

Accesswire May 31, 2024

SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX

Accesswire May 30, 2024

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.

PR Newswire May 29, 2024

SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SRDX, MRO, ATRI, CALT

PR Newswire May 29, 2024

Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders

PR Newswire May 29, 2024

SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders

Business Wire May 29, 2024

Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million

Business Wire May 29, 2024

Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Business Wire May 1, 2024